Kıvanç Çefle

1.2k total citations
71 papers, 468 citations indexed

About

Kıvanç Çefle is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Kıvanç Çefle has authored 71 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 14 papers in Genetics and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Kıvanç Çefle's work include Chronic Lymphocytic Leukemia Research (8 papers), Eosinophilic Disorders and Syndromes (5 papers) and MicroRNA in disease regulation (5 papers). Kıvanç Çefle is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Eosinophilic Disorders and Syndromes (5 papers) and MicroRNA in disease regulation (5 papers). Kıvanç Çefle collaborates with scholars based in Türkiye, United Kingdom and United States. Kıvanç Çefle's co-authors include Şükrü Palanduz, Şükrü Öztürk, Cüneyt Türkmen, Ömer Taşer, Lorenzo Minchiotti, Monica Galliano, Monica Campagnoli, Alaattin Yıldız, Bülent Zülfikar and Melih Aktan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Chemistry.

In The Last Decade

Kıvanç Çefle

62 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kıvanç Çefle Türkiye 14 209 88 65 61 56 71 468
Halil Gürhan Karabulut Türkiye 11 130 0.6× 46 0.5× 85 1.3× 36 0.6× 34 0.6× 42 369
Luca Járomi Hungary 14 236 1.1× 127 1.4× 74 1.1× 115 1.9× 72 1.3× 33 722
Kathrin Hochegger Austria 12 130 0.6× 35 0.4× 45 0.7× 65 1.1× 29 0.5× 20 505
M. Marini Italy 14 221 1.1× 37 0.4× 94 1.4× 83 1.4× 22 0.4× 31 473
Marielle Martin France 16 155 0.7× 74 0.8× 34 0.5× 32 0.5× 30 0.5× 38 637
Fiona R. Green United Kingdom 10 145 0.7× 58 0.7× 35 0.5× 52 0.9× 28 0.5× 13 556
Trang T. D. Luong Germany 12 188 0.9× 108 1.2× 21 0.3× 32 0.5× 42 0.8× 20 528
Kazumi Kuriwaki Japan 10 127 0.6× 43 0.5× 63 1.0× 87 1.4× 25 0.4× 22 373
Beina Teng Germany 15 232 1.1× 88 1.0× 21 0.3× 60 1.0× 25 0.4× 21 579
Aleksandra Nowicka Poland 10 195 0.9× 63 0.7× 33 0.5× 47 0.8× 100 1.8× 25 413

Countries citing papers authored by Kıvanç Çefle

Since Specialization
Citations

This map shows the geographic impact of Kıvanç Çefle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kıvanç Çefle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kıvanç Çefle more than expected).

Fields of papers citing papers by Kıvanç Çefle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kıvanç Çefle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kıvanç Çefle. The network helps show where Kıvanç Çefle may publish in the future.

Co-authorship network of co-authors of Kıvanç Çefle

This figure shows the co-authorship network connecting the top 25 collaborators of Kıvanç Çefle. A scholar is included among the top collaborators of Kıvanç Çefle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kıvanç Çefle. Kıvanç Çefle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Öztürk, Şükrü, et al.. (2025). MiR-7-5p May Inhibit AML Cell Proliferation Via SKP2, KLF4, OGT Target Genes. Clinical and Experimental Health Sciences. 15(1). 8–14. 1 indexed citations
3.
Palanduz, Şükrü, et al.. (2024). Overexpression of CDC25A, AURKB, and TOP2A Genes Could Be an Important Clue for Luminal A Breast Cancer. SHILAP Revista de lepidopterología. 20(4). 284–291. 2 indexed citations
4.
Palanduz, Şükrü, et al.. (2024). EFFECT of CURCUMIN on BREAST CANCER CELLS THROUGH miR-145-5p AND ITS TARGET GENES. SHILAP Revista de lepidopterología. 87(3). 235–245.
5.
Çefle, Kıvanç, et al.. (2024). Curcumin suppresses cell viability in breast cancer cell line by affecting the expression of miR-15a-5p. SHILAP Revista de lepidopterología. 49(5). 656–665. 4 indexed citations
6.
Karataş, Ömer Faruk, et al.. (2024). CDR1as/miR-7-5p/ IGF1R axis contributes to the suppression of cell viability in prostate cancer. SHILAP Revista de lepidopterología. 50(1). 89–98.
7.
Palanduz, Şükrü, et al.. (2024). Turmeric Inhibits MDA-MB-231 Cancer Cell Proliferation, Altering miR-638-5p and Its Potential Targets. SHILAP Revista de lepidopterología. 20(2). 102–109. 5 indexed citations
8.
Özgür, Emre, Ömer Faruk Karataş, Şükrü Öztürk, et al.. (2023). miR-145-5p suppresses cell proliferation by targeting IGF1R and NRAS genes in multiple myeloma cells. SHILAP Revista de lepidopterología. 48(5). 563–569. 7 indexed citations
9.
Yavuz, Akif Selim, et al.. (2022). OCT-1 Expression in Patients with Chronic Myeloid Leukemia: A Comparative Analysis with Respect to Response to Imatinib Treatment. Indian Journal of Hematology and Blood Transfusion. 38(4). 668–674.
10.
Dirim, Ahmet Burak, Seda Şafak, Seyhun Solakoğlu, et al.. (2022). Heme oxygenase-1 deficiency as an extremely rare cause of AA-type renal amyloidosis: Expanding the clinical features and review of the literature. Clinical Rheumatology. 42(2). 597–606. 2 indexed citations
11.
Erdem, Simge, Veysel Sabri Hançer, Meliha Nalçacı, et al.. (2021). A case mimicking chronic myeloid leukemia with t(8;22)(p11;q11)/BCR-FGFR1 and sequential transformation to B-acute lymphoblastic leukemia and acute myeloid leukemia. Journal of Hematopathology. 14(2). 151–156.
12.
13.
Öztürk, Şükrü, et al.. (2013). Genotoxicity of fixation devices analyzed by the frequencies of sister chromatid exchange. Ulusal travma dergisi. 19(4). 299–304. 1 indexed citations
14.
Aktan, Melih, Şükrü Öztürk, Şükrü Palanduz, et al.. (2011). Investigation of Arg399Gln and Arg194Trp Polymorphisms of the XRCC1 (X-Ray Cross-Complementing Group 1) Gene and Its Correlation to Sister Chromatid Exchange Frequency in Patients with Chronic Lymphocytic Leukemia. Genetic Testing and Molecular Biomarkers. 16(4). 287–291. 15 indexed citations
15.
Palanduz, Şükrü, Burçak Vural, Kıvanç Çefle, et al.. (2009). Comparison of the Cytogenetic and Molecular Analyses in the Assessment of Imatinib Response in Chronic Myelocytic Leukemia. Genetic Testing and Molecular Biomarkers. 13(5). 599–602. 1 indexed citations
16.
Öztürk, Şükrü, Kıvanç Çefle, Şükrü Palanduz, et al.. (2008). Effect of Cyclosporin A and Tacrolimus on Sister Chromatid Exchange Frequency in Renal Transplant Patients. Genetic Testing. 12(3). 427–430. 14 indexed citations
17.
Çefle, Kıvanç, et al.. (2008). The effect of parental consanguinity on the clinical and laboratory findings of rheumatoid arthritis. International Journal of Clinical Practice. 63(7). 1056–1060. 1 indexed citations
18.
Yönal, Oya, Özden Hatırnaz Ng, Filiz Akyüz, et al.. (2007). Definition of C282Y mutation in a hereditary hemochromatosis family from Turkey.. PubMed. 18(1). 53–7. 5 indexed citations
19.
Türkmen, Cüneyt, Şükrü Öztürk, Seher Ünal, et al.. (2007). The Genotoxic Effects in Lymphocyte Cultures of Children Treated with Radiosynovectomy by Using Yttrium-90 Citrate Colloid. Cancer Biotherapy and Radiopharmaceuticals. 22(3). 393–399. 19 indexed citations
20.
Palanduz, Şükrü, et al.. (1999). Genotoxic potential of cyclosporin A in patients with renal transplantation. Cell Biology and Toxicology. 15(1). 13–17. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Halil Gürhan Karabulut Breakdown of academic impact, for papers by Luca Járomi Breakdown of academic impact, for papers by Kathrin Hochegger Breakdown of academic impact, for papers by M. Marini Breakdown of academic impact, for papers by Marielle Martin Breakdown of academic impact, for papers by Fiona R. Green Breakdown of academic impact, for papers by Trang T. D. Luong Breakdown of academic impact, for papers by Kazumi Kuriwaki Breakdown of academic impact, for papers by Beina Teng Breakdown of academic impact, for papers by Aleksandra Nowicka
Rankless by CCL
2026